Navigation Links
BioFortis Wins Best Product Award in Discovery Informatics at the 2009 Molecular Medicine Tri-Conference
Date:3/5/2009

Biomedical Informatics Market Leader BioFortis wins another award for its Labmatrix(TM) platform being used by leading pharmaceutical and institutional clients worldwide for translational research, biomarker discovery, biobanking, and clinical research

COLUMBIA, Md., March 5 /PRNewswire/ -- BioFortis, Inc., the leading provider of biomedical informatics solutions used by pharmaceutical and institutional clients, today announced it has won the 2009 Molecular Medicine Tri-Conference "Best Product Award" for its leading Labmatrix(TM) platform. The award is given to the best peer-reviewed solution at the annual conference.

The Best Product Award honored companies that launched the best products at the 2009 Molecular Medicine Tri-Conference. Approximately 2600 attendees of the conference were invited to vote on the contestants' products and the winners were announced at a special ceremony.

Labmatrix(TM) was designed as a solution to enable a comprehensive "bench-to-bedside" approach to the study of human diseases, while permitting collaboration in a secure environment that facilitates regulatory compliance. Labmatrix(TM) provides a clear competitive advantage for organizations that must keep pace in an era of new, high-throughput technologies utilized in discovery programs focused on next-generation therapeutics. BioFortis is the leader in information management for translational research, biomarker discovery, biobanking and clinical research, supporting multiple pharmaceutical clients and research institutions in their mission of speeding drug discovery and driving personalized medicine into practice.

"We are thrilled to win this award," said Jian Wang, BioFortis CEO, "especially considering it is an award voted on by researchers directly. This validates our mission to create data management and exploration tools that are so easy scientists can use effectively from day one. This award reaffirms our leadership position in providing informatics solutions for translational and biomarker researchers."

About BioFortis

BioFortis is a leading provider of biomedical informatics solutions. Our lead product, Labmatrix(TM), addresses research needs of the post-genomic era within several key application areas including translational research, biobanking, biomarker discovery and clinical research. Labmatrix(TM) is a web-based software application for the management and exploration of clinical, specimen and molecular assay data. With the ability to integrate these data sets in a tightly linked, highly annotated manner, Labmatrix(TM) is being used by customers in the biopharmaceutical industry, academia and government research institutions.

BioFortis and Labmatrix(TM) are registered trademarks of BioFortis, Inc.

www.biofortis.com


'/>"/>
SOURCE BioFortis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. House Committee Vote Sets Congress on Course for Historic Regulation of Tobacco Products
2. On March 4, 2009, The United States Supreme Court Rejected the Rationale Behind Michigans Drug Product Liability Law
3. MedX Health Receives CE Mark for Laser & Light Products
4. a la mode Bra Fitting Specialty Boutique Now Has Trained Fitters and Products for Women Who Are Post Op Mastectomy or Lumpectomy
5. Johnson Institute Transfers Key Programs and Products to Hazelden Foundation
6. Congress Can Deliver Historic Victory for Children and Americas Health By Granting FDA Authority Over Tobacco Products
7. Best New Product Awards Winners Named at Molecular Medicine Tri-Conference
8. Halo Pharmaceutical Launches a Branded Product Marketing Company in Canada
9. Prudential Long-Term Care Product Simplifies Decisions
10. Natural Products Association Comments on New GAO Report on Regulation of Dietary Supplements
11. Thermogenesis Technology Products Surpass Processing of More Than One Million Units of Cord Blood Stem Cells at 10-Year Milestone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... April 27, 2017 , ... Are you investing in the ... water-related accidents and drownings during the summer. While most of us assume this type ... occur every day. Very few people are taking the time to learn how to ...
(Date:4/26/2017)... ... April 26, 2017 , ... Intalere, the ... the podcast, “Make Plans for MACRA,” highlighting the impact of the ... office and how physicians and other clinicians are reimbursed for the care they ...
(Date:4/26/2017)... ... 2017 , ... CareSet Labs today is releasing an important ... Part D Medicare data. The dataset, called PaPR (Providers and Prescribing Records) details ... paper. The PaPR (pronounced "paper") data set aggregates this information on a ...
(Date:4/26/2017)... ... April 26, 2017 , ... The National Business Research ... National Registry of Emergency Medical Technicians and welcomes this organization to the ... Jan G. West, Ph.D. , CEO & Organizational Psychologist at NBRI. “This award ...
(Date:4/26/2017)... ... ... RawTrition now brings you BioEnergy which is a powder capsule whole food ... RawTrition is taking nutrients to the next level! The superfoods in RawTrition's BioEnergy ... (unlike the synthetically made options that are on the market). , Founder of RawTrition, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... MARLBOROUGH, Mass. , April 20, 2017 /PRNewswire/ ... company developing innovative therapeutics that address significant unmet ... new data from the Company,s consumer product development ... technology, at the Society for Investigative Dermatology (SID) ... is to advance and promote the sciences relevant ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2014 ... ... US$ 7,167.6 Mn in 2015, and is expected to reach ... 5.6% from 2016 to 2024. The global ...
(Date:4/19/2017)... -- Cardiology devices segment is anticipated to reach the highest ... Devices segment is likely to create absolute $ opportunity of ... 2017. By the end of 2027, Cardiology Devices segment is ... Mn, expanding at a CAGR of 18.4% over the forecast ... Pacific reprocessed medical devices market in terms of ...
Breaking Medicine Technology: